Table 7. Estimated new cancer cases and death caused by HBV and HCV in 2012, by country.

Country		Hepatocellular carcinoma HBV-related		Cholangio- carcinoma HBV-related		Hepatocellular carcinoma HCV-related		Cholangio- carcinoma HCV-related		Non-Hodgkin’s lymphoma HCV-related		Percentagea
		Male	Female	Male	Female	Male	Female	Male	Female	Male	Female
Korea	New cases	6670	2428	355	90	1481	654	38	16	64	68	54.88%
	Deaths	3824	1330	461	120	849	358	50	21	23	22	50.83%
China	New cases	154 616	47 390	6965	1829	64 048	23 174	5069	1852	1160	778	70.17%
	Deaths	148 545	47 366	6692	1828	61 533	23 162	4870	1852	738	466	72.51%
Japan	New cases	2461	975	12	5	2163	1145	37	20	144	132	12.41%
	Deaths	2178	828	11	4	1914	972	33	17	80	67	14.29%
Indonesia	New cases	5174	1841	168	60	2168	771	162	58	237	170	34.37%
	Deaths	4899	1750	159	57	2052	733	154	55	31	115	45.61%
Philippines	New cases	3021	1273	148	62	211	89	14	6	8	7	48.14%
	Deaths	2916	1211	142	59	203	84	14	6	5	4	52.43%
Thailand	New cases	3902	1385	1217	389	1077	418	582	226	56	44	38.09%
	Deaths	3705	1320	1156	370	1023	398	553	215	39	30	39.77%
Vietnam	New cases	9671	2678	503	117	3496	1077	274	84	65	46	73.01%
	Deaths	9199	2545	478	111	3326	1024	260	80	45	32	75.11%
Bangladesh	New cases	781	475	27	16	84	54	6	4	11	6	27.58%
	Deaths	741	455	26	15	80	52	5	3	8	5	30.33%
India	New cases	5591	3302	161	95	2108	1245	152	90	347	173	25.90%
	Deaths	5435	3246	156	93	2049	1224	148	88	242	121	29.52%
Iran	New cases	174	110	4	2	21	16	1	1	7	5	7.07%
	Deaths	166	105	4	2	20	15	1	1	5	3	9.26%
Pakistan	New cases	1040	552	32	17	819	435	70	37	245	148	33.00%
	Deaths	987	528	31	16	778	416	66	35	179	109	37.05%
Turkey	New cases	646	290	22	10	156	99	11	7	51	56	18.63%
	Deaths	613	277	21	10	148	94	10	7	31	34	23.94%
Saudi Arabia	New cases	126	50	3	1	157	63	14	5	51	37	25.76%
	Deaths	118	48	3	1	148	60	13	5	28	21	32.39%

HBV, hepatitis B virus; HCV, hepatitis C virus.

^aThe proportion of HBV- and HCV-induced new cancer cases/deaths in all these cancers cases/deaths.